Tetraspanins and malignancy

Expert Reviews in Molecular Medicine

Volumn 3, Issue 4, 2001, Pages 1-17

  Boucheix, Claude ^a   Duc, Guy Huynh Thien ^a   Jasmin, Claude ^a   Rubinstein, Eric ^a  

^a HÔPITAL PAUL BROUSSE   (France)

Author keywords

cancer; cancer cell migration; fusion; integration; malignancy; tetraspanin; TM4SF

Indexed keywords

EID: 85012505212     PISSN: 14623994     EISSN: 14623994     Source Type: Journal    
DOI: 10.1017/S1462399401002381     Document Type: Article

References (112)

1. Wright, M.D. and Tomlinson, M.G. (1994) The ins and outs of the transmembrane 4 superfamily. Immunol Today 15, 588–594, PubMed ID: 95151148
2. Maecker, H.T., Todd, S.C. and Levy, S. (1997) The tetraspanin superfamily: molecular facilitators. Faseb J 11, 428–442, PubMed ID: 97337829
3. Rubinstein, E. and Boucheix, C. (1999) Tetraspans. In Guidebook to the Extracellular Matrix and Adhesion Proteins (Kreis, T. and Vale, R., eds), pp. 321–324, Oxford University Press, Oxford
4. Szala, S. et al. (1990) Molecular cloning of cDNA for the human tumor-associated antigen CO-029 and identification of related transmembrane antigens. Proc Natl Acad Sci U S A 87, 6833–6837, PubMed ID: 90370878
5. Jankowski, S.A. et al. (1994) SAS, a gene amplified in human sarcomas, encodes a new member of the transmembrane 4 superfamily of proteins. Oncogene 9, 1205–1211, PubMed ID: 94181273
6. Sun, T.T. et al. (1996) Formation of asymmetric unit membrane during urothelial differentiation. Mol Biol Rep 23, 3–11, PubMed ID: 97137677
7. van Soest, S. et al. (1999) Retinitis pigmentosa: defined from a molecular point of view. Surv Ophthalmol 43, 321–334, PubMed ID: 99148381
8. Todd, S.C., Doctor, V.S. and Levy, S. (1998) Sequences and expression of six new members of the tetraspanin/TM4SF family. Biochim Biophys Acta 1399, 101–104, PubMed ID: 98390278
9. Serru, V. et al. (2000) Sequence and expression of seven new tetraspans. Biochim Biophys Acta 1478, 159–163, PubMed ID: 20185353
10. Puls, K.L. et al. (1999) The molecular characterisation of a novel tetraspanin protein, TM4-B(1). Biochim Biophys Acta 1447, 93–99, PubMed ID: 99431564
11. Wright, M.D., Ni, J. and Rudy, G.B. (2000) The L6 membrane proteins-a new four-transmembrane superfamily. Protein Sci 9, 1594–1600, PubMed ID: 20427321
12. Crosbie, R.H. et al. (1997) Sarcospan, the 25-kDa transmembrane component of the dystrophin-glycoprotein complex. J Biol Chem 272, 31221–31224, PubMed ID: 98058898
13. Oren, R. et al. (1990) TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Mol Cell Biol 10, 4007–4015, PubMed ID: 90318365
14. Lebel-Binay, S. et al. (1995) CD82, member of the tetra-span-transmembrane protein family, is a costimulatory protein for T cell activation. J Immunol 155, 101–110, PubMed ID: 95325577
15. Lagaudriere-Gesbert, C. et al. (1997) Functional analysis of four tetraspans, CD9, CD53, CD81, and CD82, suggests a common role in costimulation, cell adhesion, and migration: only CD9 upregulates HB-EGF activity. Cell Immunol 182, 105–112, PubMed ID: 98189267
16. Stipp, C.S. and Hemler, M.E. (2000) Transmembrane-4-superfamily proteins CD151 and CD81 associate with alpha 3 beta 1 integrin, and selectively contribute to alpha 3 beta 1-dependent neurite outgrowth. J Cell Sci 113, 1871–1882, PubMed ID: 20267869
17. Shaw, A.R. et al. (1995) Ectopic expression of human and feline CD9 in a human B cell line confers beta 1 integrin-dependent motility on fibronectin and laminin substrates and enhanced tyrosine phosphorylation. J Biol Chem 270, 24092–24099, PubMed ID: 96025791
18. Worthington, R.E., Carroll, R.C. and Boucheix, C. (1990) Platelet activation by CD9 monoclonal antibodies is mediated by the Fc gamma II receptor. Br J Haematol 74, 216–222, PubMed ID: 90198863
19. Rubinstein, E. et al. (1995) Anti-platelet antibody interactions with Fc gamma receptor. Semin Thromb Hemost 21, 10–22, PubMed ID: 95327962
20. Miyake, M. et al. (1991) Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31–15, which inhibits cell motility. J Exp Med 174, 1347–1354, PubMed ID: 92078843
21. Radford, K.J., Thorne, R.F. and Hersey, P. (1997) Regulation of tumor cell motility and migration by CD63 in a human melanoma cell line. J Immunol 158, 3353–3358, PubMed ID: 97240780
22. Anton, E.S. et al. (1995) CD9 plays a role in Schwann cell migration in vitro. J Neurosci 15, 584–595, PubMed ID: 95123483
23. Sugiura, T. and Berditchevski, F. (1999) Function of alpha3beta1-tetraspanin protein complexes in tumor cell invasion. Evidence for the role of the complexes in production of matrix metalloproteinase 2 (MMP-2). J Cell Biol 146, 1375–1389, PubMed ID: 99423676
24. Park, K.R. et al. (2000) Anti-CD9 monoclonal antibody-stimulated invasion of endometrial cancer cell lines in vitro: possible inhibitory effect of CD9 in endometrial cancer invasion. Mol Hum Reprod 6, 719–725, PubMed ID: 20368857
25. Ikeyama, S. et al. (1993) Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J Exp Med 177, 1231–1237, PubMed ID: 93240104
26. Testa, J.E. et al. (1999) Eukaryotic expression cloning with an antimetastatic monoclonal antibody identifies a tetraspanin (PETA-3/ CD151) as an effector of human tumor cell migration and metastasis. Cancer Res 59, 3812–3820, PubMed ID: 99374666
27. Hemler, M.E., Mannion, B.A. and Berditchevski, F. (1996) Association of TM4SF proteins with integrins: relevance to cancer. Biochim Biophys Acta 1287, 67–71, PubMed ID: 96270769
28. McClatchey, A.I. (1999) Modeling metastasis in the mouse. Oncogene 18, 5334–5339, PubMed ID: 99429939
29. Tsitsikov, E.N., Gutierrez-Ramos, J.C. and Geha, R.S. (1997) Impaired CD19 expression and signaling, enhanced antibody response to type II T independent antigen and reduction of B-1 cells in CD81-deficient mice. Proc Natl Acad Sci U S A 94, 10844–10849, PubMed ID: 98021456
30. Miyazaki, T., Muller, U. and Campbell, K.S. (1997) Normal development but differentially altered proliferative responses of lymphocytes in mice lacking CD81. Embo J 16, 4217–4225, PubMed ID: 97392451
31. Maecker, H.T., Do, M.S. and Levy, S. (1998) CD81 on B cells promotes interleukin 4 secretion and antibody production during T helper type 2 immune responses. Proc Natl Acad Sci U S A 95, 2458–2462, PubMed ID: 98151534
32. Knobeloch, K.P. et al. (2000) Targeted inactivation of the tetraspanin CD37 impairs T-cell-dependent B-cell response under suboptimal costimulatory conditions. Mol Cell Biol 20, 5363–5369, PubMed ID: 20351574
33. Le Naour, F. et al. (2000) Severely reduced female fertility in CD9-deficient mice. Science 287, 319–321, PubMed ID: 20102835
34. Miyado, K. et al. (2000) Requirement of CD9 on the egg plasma membrane for fertilization. Science 287, 321–324, PubMed ID: 20102836
35. Kaji, K. et al. (2000) The gamete fusion process is defective in eggs of Cd9-deficient mice. Nat Genet 24, 279–282, PubMed ID: 20164327
36. Chen, M.S. et al. (1999) Role of the integrin-associated protein CD9 in binding between sperm ADAM 2 and the egg integrin alpha6beta1: implications for murine fertilization. Proc Natl Acad Sci U S A 96, 11830–11835, PubMed ID: 99449768
37. Rubinstein, E. et al. (1996) CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins. Eur J Immunol 26, 2657–2665, PubMed ID: 97080607
38. Miller, B.J. et al. (2000) Normal fertilization occurs with eggs lacking the integrin alpha6beta1 and is CD9-dependent. J Cell Biol 149, 1289–1296, PubMed ID: 20309834
39. Zemni, R. et al. (2000) A new gene involved in X-linked mental retardation identified by analysis of an X;2 balanced translocation. Nat Genet 24, 167–170, PubMed ID: 20120717
40. Imai, T. and Yoshie, O. (1993) C33 antigen and M38 antigen recognized by monoclonal antibodies inhibitory to syncytium formation by human T cell leukemia virus type 1 are both members of the transmembrane 4 superfamily and associate with each other and with CD4 or CD8 in T cells. J Immunol 151, 6470–6481, PubMed ID: 94065201
41. Fearon, D.T. and Carter, R.H. (1995) The CD19/ CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu Rev Immunol 13, 127–149, PubMed ID: 95336673
42. Tedder, T.F., Zhou, L.J. and Engel, P. (1994) The CD19/CD21 signal transduction complex of B lymphocytes. Immunol Today 15, 437–442, PubMed ID: 95032569
43. Rubinstein, E. et al. (1994) CD9 antigen is an accessory subunit of the VLA integrin complexes. Eur J Immunol 24, 3005–3013, PubMed ID: 95104284
44. Berditchevski, F., Bazzoni, G. and Hemler, M.E. (1995) Specific association of CD63 with the VLA-3 and VLA-6 integrins. J Biol Chem 270, 17784–17790, PubMed ID: 95355368
45. Mitamura, T. et al. (1992) The 27-kD diphtheria toxin receptor-associated protein (DRAP27) from vero cells is the monkey homologue of human CD9 antigen: expression of DRAP27 elevates the number of diphtheria toxin receptors on toxin-sensitive cells. J Cell Biol 118, 1389–1399, PubMed ID: 92394967
46. Higashiyama, M. et al. (1995) Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer. Cancer Res 55, 6040–6044, PubMed ID: 96105018
47. Secrist, H. et al. (1996) Ligation of TAPA-1 (CD81) or major histocompatibility complex class II in co-cultures of human B and T lymphocytes enhances interleukin-4 synthesis by antigen-specific CD4+ T cells. Eur J Immunol 26, 1435–1442, PubMed ID: 96305397
48. Angelisova, P., Hilgert, I. and Horejsi, V. (1994) Association of four antigens of the tetraspans family (CD37, CD53, TAPA- 1, and R2/C33) with MHC class II glycoproteins. Immunogenetics 39, 249–256, PubMed ID: 94164694
49. Nakamura, K., Iwamoto, R. and Mekada, E. (1995) Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites. J Cell Biol 129, 1691–1705, PubMed ID: 95310347
50. Berditchevski, F., Zutter, M.M. and Hemler, M.E. (1996) Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembrane domains (TM4 proteins). Mol Biol Cell 7, 193–207, PubMed ID: 96228680
51. Radford, K.J., Thorne, R.F. and Hersey, P. (1996) CD63 associates with transmembrane 4 superfamily members, CD9 and CD81, and with beta 1 integrins in human melanoma. Biochem Biophys Res Commun 222, 13–18, PubMed ID: 96212905
52. Serru, V. et al. (1999) Selective tetraspan-integrin complexes (CD81/alpha4beta1, CD151/ alpha3beta1, CD151/alpha6beta1) under conditions disrupting tetraspan interactions. Biochem J 340, 103–111, PubMed ID: 99247901
53. Horvath, G. et al. (1998) CD19 is linked to the integrin-associated tetraspans CD9, CD81, and CD82. J Biol Chem 273, 30537–30543, PubMed ID: 99023984
54. Berditchevski, F. and Odintsova, E. (1999) Characterization of integrin-tetraspanin adhesion complexes: role of tetraspanins in integrin signaling. J Cell Biol 146, 477–492, PubMed ID: 99357849
55. Sato, S. et al. (1997) Regulation of B lymphocyte development and activation by the CD19/CD21/ CD81/Leu 13 complex requires the cytoplasmic domain of CD19. J Immunol 159, 3278–3287, PubMed ID: 97461445
56. Nakamura, K. et al. (2000) Importance of the major extracellular domain of CD9 and the epidermal growth factor (EGF)-like domain of heparin-binding EGF-like growth factor for up-regulation of binding and activity. J Biol Chem 275, 18284–18290, PubMed ID: 20309780
57. Yauch, R.L. et al. (1998) Highly stoichiometric, stable, and specific association of integrin alpha3beta1 with CD151 provides a major link to phosphatidylinositol 4- kinase, and may regulate cell migration. Mol Biol Cell 9, 2751–2765, PubMed ID: 98437182
58. Willett, B.J., Flynn, J.N. and Hosie, M.J. (1997) FIV infection of the domestic cat: an animal model for AIDS. Immunol Today 18, 182–189, PubMed ID: 97282208
59. Loffler, S. et al. (1997) CD9, a tetraspan transmembrane protein, renders cells susceptible to canine distemper virus. J Virol 71, 42–49, PubMed ID: 97138295
60. Schmid, E. et al. (2000) Antibodies to CD9, a tetraspan transmembrane protein, inhibit canine distemper virus-induced cell-cell fusion but not virus-cell fusion. J Virol 74, 7554–7561, PubMed ID: 20366312
61. Rice, C.M. (1999) Is CD81 the key to hepatitis C virus entry? Hepatology 29, 990–992, PubMed ID: 99162398
62. Pileri, P. et al. (1998) Binding of hepatitis C virus to CD81. Science 282, 938–941, PubMed ID: 99011351
63. Higginbottom, A. et al. (2000) Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2. J Virol 74, 3642–3649, PubMed ID: 20193804
64. Meola, A. et al. (2000) Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection. J Virol 74, 5933–5938, PubMed ID: 20304985
65. Kersey, J.H. et al. (1981) P-24: a human leukemia-associated and lymphohemopoietic progenitor cell surface structure identified with monoclonal antibody. J Exp Med 153, 726–731, PubMed ID: 81241301
66. Boucheix, C. et al. (1985) A new set of monoclonal antibodies against acute lymphoblastic leukemia. Leuk Res 9, 597–604, PubMed ID: 0002409408
67. Lo Coco, F. et al. (1989) Immunophenotyping of acute myeloid leukaemia: relevance of analysing different lineage-associated markers. Blut 58, 235–240, PubMed ID: 89247882
68. Takagi, S. et al. (1995) Identification of a highly specific surface marker of T-cell acute lymphoblastic leukemia and neuroblastoma as a new member of the transmembrane 4 superfamily. Int J Cancer 61, 706–715, PubMed ID: 95286314
69. Ono, Y., Fukuhara, N. and Yoshie, O. (1997) Transcriptional activity of TAL1 in T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL. J Biol Chem 272, 4576–4581, PubMed ID: 97172541
70. Marken, J.S. et al. (1992) Cloning and expression of the tumor-associated antigen L6. Proc Natl Acad Sci U S A 89, 3503–3507, PubMed ID: 92228814
71. Hotta, H. et al. (1988) Molecular cloning and characterization of an antigen associated with early stages of melanoma tumor progression. Cancer Res 48, 2955–2962, PubMed ID: 88210273
72. Dong, J.T. et al. (1995) KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 268, 884–886, PubMed ID: 95273964
73. Dong, J.T. et al. (1996) Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Cancer Res 56, 4387–4390, PubMed ID: 96408086
74. Guo, X.Z. et al. (1998) KAI1, a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma. Hepatology 28, 1481–1488, PubMed ID: 99047491
75. Adachi, M. et al. (1996) Correlation of KAI1/ CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res 56, 1751–1755, PubMed ID: 96184963
76. Lombardi, D.P. et al. (1999) Loss of KAI1 expression in the progression of colorectal cancer. Cancer Res 59, 5724–5731, PubMed ID: 20047516
77. Adachi, M. et al. (1998) Novel staging protocol for non-small-cell lung cancers according to MRP- 1/CD9 and KAI1/CD82 gene expression. J Clin Oncol 16, 1397–1406, PubMed ID: 98211769
78. Nees, M. et al. (1998) Identification of novel molecular markers which correlate with HPV-induced tumor progression. Oncogene 16, 2447–2458, PubMed ID: 98288800
79. Miyake, M. et al. (1995) Motility related protein 1 (MRP-1/CD9) expression: inverse correlation with metastases in breast cancer. Cancer Res 55, 4127–4131, PubMed ID: 95393418
80. Uchida, S. et al. (1999) Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma. Br J Cancer 79, 1168–1173, PubMed ID: 99196389
81. Guo, X. et al. (1996) KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases. Cancer Res 56, 4876–4880, PubMed ID: 97050998
82. Sun, H.C. et al. (1998) KAI1 gene expression in hepatocellular carcinoma and its relationship with intrahepatic metastases. J Exp Clin Cancer Res 17, 307–311, PubMed ID: 99110058
83. Maurer, C.A. et al. (1999) Reduced expression of the metastasis suppressor gene KAI1 in advanced colon cancer and its metastases. Surgery 126, 869–880, PubMed ID: 20034182
84. Huang, C.I. et al. (1998) Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients. Am J Pathol 153, 973–983, PubMed ID: 98405453
85. Cajot, J.F. et al. (1997) Differential display cloning identifies motility-related protein (MRP1/CD9) as highly expressed in primary compared to metastatic human colon carcinoma cells. Cancer Res 57, 2593–2597, PubMed ID: 97349057
86. Radford, K.J., Mallesch, J. and Hersey, P. (1995) Suppression of human melanoma cell growth and metastasis by the melanoma-associated antigen CD63 (ME491). Int J Cancer 62, 631–635, PubMed ID: 95394527
87. Claas, C. et al. (1998) Association between the rat homologue of CO-029, a metastasis- associated tetraspanin molecule and consumption coagulopathy. J Cell Biol 141, 267–280, PubMed ID: 98198483
88. Keely, P., Parise, L. and Juliano, R. (1998) Integrins and GTPases in tumour cell growth, motility and invasion. Trends Cell Biol 8, 101–106, PubMed ID: 98360931
89. Boudreau, N. and Bissell, M.J. (1998) Extracellular matrix signaling: integration of form and function in normal and malignant cells. Curr Opin Cell Biol 10, 640–646, PubMed ID: 99035564
90. Berditchevski, F. et al. (1997) A novel link between integrins, transmembrane-4 superfamily proteins (CD63 and CD81), and phosphatidylinositol 4-kinase. J Biol Chem 272, 2595–2598, PubMed ID: 97160557
91. Mandel, U. et al. (1994) Oncofetal fibronectins in oral carcinomas: correlation of two different types. Apmis 102, 695–702, PubMed ID: 95033136
92. Kosmehl, H. et al. (1999) Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma. Br J Cancer 81, 1071–1079, PubMed ID: 20042086
93. Miyazaki, T. et al. (2000) Mutation and expression of the metastasis suppressor gene KAI1 in esophageal squamous cell carcinoma. Cancer 89, 955–962, PubMed ID: 20419754
94. Mashimo, T. et al. (1998) The expression of the KAI1 gene, a tumor metastasis suppressor, is directly activated by p53. Proc Natl Acad Sci U S A 95, 11307–11311, PubMed ID: 98409653
95. Duriez, C. et al. (2000) Absence of p53-dependent induction of the metastatic suppressor KAI1 gene after DNA damage. Oncogene 19, 2461–2464, PubMed ID: 20291573
96. Ow, K. et al. (2000) Relationship between expression of the KAI1 metastasis suppressor and other markers of advanced bladder cancer. J Pathol 191, 39–47, PubMed ID: 20231975
97. Boucheix, C. et al. (1991) Molecular cloning of the CD9 antigen. A new family of cell surface proteins. J Biol Chem 266, 117–122, PubMed ID: 91093112
98. Lagaudriere-Gesbert, C. et al. (1997) The tetraspanin protein CD82 associates with both free HLA class I heavy chain and heterodimeric beta 2-microglobulin complexes. J Immunol 158, 2790–2797, PubMed ID: 97211847
99. Jones, P.H., Bishop, L.A. and Watt, F.M. (1996) Functional significance of CD9 association with beta 1 integrins in human epidermal keratinocytes. Cell Adhes Commun 4, 297–305, PubMed ID: 97173254
100. Yanez-Mo, M. et al. (1998) Regulation of endothelial cell motility by complexes of tetraspan molecules CD81/TAPA-1 and CD151/ PETA-3 with alpha3 beta1 integrin localized at endothelial lateral junctions. J Cell Biol 141, 791–804, PubMed ID: 98234412
101. Sincock, P.M. et al. (1999) PETA-3/CD151, a member of the transmembrane 4 superfamily, is localised to the plasma membrane and endocytic system of endothelial cells, associates with multiple integrins and modulates cell function. J Cell Sci 112, 833–844, PubMed ID: 99156996
102. Takaoka, A. et al. (1998) Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene. Oncogene 16, 1443–1453, PubMed ID: 98184656
103. Kleinman, H.K. et al. (1986) Basement membrane complexes with biological activity. Biochemistry 25, 312–318, PubMed ID: 86159711
104. Mackay, A.R. et al. (1993) Identification of the 72-kDa (MMP-2) and 92-kDa (MMP-9) gelatinase/ type IV collagenase in preparations of laminin and Matrigel. Biotechniques 15, 1048–1051, PubMed ID: 94121883
105. Si, Z. and Hersey, P. (1993) Expression of the neuroglandular antigen and analogues in melanoma. CD9 expression appears inversely related to metastatic potential of melanoma. Int J Cancer 54, 37–43, PubMed ID: 93239379
106. Miyake, M. et al. (1996) Motility-related protein-1 (MRP-1/CD9) reduction as a factor of poor prognosis in breast cancer. Cancer Res 56, 1244–1249, PubMed ID: 96189296
107. Mori, M. et al. (1998) Motility related protein 1 (MRP1/CD9) expression in colon cancer. Clin Cancer Res 4, 1507–1510, PubMed ID: 98289771
108. Sho, M. et al. (1998) Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer. Int J Cancer 79, 509–516, PubMed ID: 98432265
109. Miyake, M. et al. (1999) A novel molecular staging protocol for non-small cell lung cancer. Oncogene 18, 2397–2404, PubMed ID: 99256993
110. Miyake, M. et al. (1999) A novel molecular staging protocol for non-small cell lung cancer. Oncogene 18, 2397–2404, PubMed ID: 99256993
111. Stipp, C.S. et al. (2001) FPRP: a major, highly stoichiometric, highly specific CD81 and CD9-associated protein. J Biol Chem 276, 4853–4862
112. Charrin, S. et al. (2001) The major CD9 and CD81 molecular partner: Identification and characterization of the complexes. J Biol Chem 276, 14329–14337